Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review
A. Cortegiani; M. Ippolito; M. Greco; V. Granone; A. Protti; C. Gregoretti; A. Giarratano; S. Einav; M. Cecconi;
Pulmonol. 2021;27:52-66
Predictors of intubation in COVID-19 patients treated with out-of-ICU continuous positive airway pressure
N. De Vita; L. Scotti; G. Cammarota; F. Racca; C. Pissaia; C. Maestrone; D. Colombo; C. Olivieri; F. Della Corte; F. Barone-Adesi; P. Navalesi; R. Vaschetto;
Pulmonol. 2022;28:173-80
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
Seyed MohammadReza Hashemian; Navid Shafigh; Golnaz Afzal; Hamidreza Jamaati; Payam Tabarsi; Majid Marjani; Majid Malekmohammad; Seyed Mehdi Mortazavi; Batoul Khoundabi; Davood Mansouri; Afshin Moniri; Abbas Hajifathali; Elham Roshandel; Esmaeil Mortaz; Ian M Adcock;
Pulmonol. 2021;27:486-92